← Back to Search

Behavioural Intervention

High Intensity Interval Training for Congenital Heart Disease

N/A
Recruiting
Led By Michael Khoury, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children and adolescents aged 10-18 years
Repaired moderate-complex congenital heart disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention
Awards & highlights

Study Summary

This trial will study the effects of a home-based high intensity interval training program on exercise capacity in adolescents with repaired congenital heart disease.

Who is the study for?
This trial is for children and teens aged 10-18 with repaired moderate-complex congenital heart disease. They must speak English, have space at home for the MedBIKE system, and not be restricted from exercising by their cardiologist. Those with severe symptoms, cognitive impairments affecting communication, or recent serious arrhythmias cannot participate.Check my eligibility
What is being tested?
The study tests a home-based high-intensity interval training (HIIT) program using a telemedicine-equipped video game-linked cycle ergometer called MedBIKE™. It aims to improve exercise capacity in youth with congenital heart disease through this novel cardiac rehabilitation approach.See study design
What are the potential side effects?
While specific side effects are not listed, HIIT programs can generally cause increased heart rate during exercise, fatigue afterwards, muscle soreness and may pose risks if there's an underlying health condition that hasn't been adequately assessed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 18 years old.
Select...
I had surgery to fix a moderate to complex heart defect.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-week post-intervention, 6-months post-intervention, 12-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise capacity in the change in VO2peak (mL/kg/min) measured through CPET testing
Secondary outcome measures
Changes in Health-Related Quality of Life as measured using the TNO AZL Children's Quality of Life (TACQOL) questionnaire.
Changes in endothelial function to determine arterial volume will be measured using an EndoPAT 2000 instrument.
Changes in physical activity, defined as time spent in moderate to vigorous physical activity (MVPA) and sedentary time, measured by wearing an accelerometer for 7-days prior and 7-days post MedBIKE intervention
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: MedBIKE HIITExperimental Treatment1 Intervention
MedBIKE HIIT Exercise Program

Find a Location

Who is running the clinical trial?

Heart and Stroke Foundation of CanadaOTHER
122 Previous Clinical Trials
72,066 Total Patients Enrolled
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,090 Total Patients Enrolled
Michael Khoury, MDPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

MedBIKE HIIT (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04575883 — N/A
Congenital Heart Disease Research Study Groups: MedBIKE HIIT
Congenital Heart Disease Clinical Trial 2023: MedBIKE HIIT Highlights & Side Effects. Trial Name: NCT04575883 — N/A
MedBIKE HIIT (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04575883 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many enrollees are participating in this experiment?

"Affirmative. Records on clinicaltrials.gov verify that this medical study, first advertised on November 22nd 2022, is currently accepting participants. Approximately 44 individuals are sought from one healthcare facility."

Answered by AI

Is this experiment currently seeking participants?

"Indeed, data hosted on clinicaltrials.gov corroborates that this medical experiment is actively searching for participants. This trial was first posted on November 22nd 2022 and has been updated recently on the 25th of November 2022 with a demand for 44 patients from 1 location."

Answered by AI

Might I qualify for participation in this medical experiment?

"This experiment calls for 44 participants between the ages of 10 and 18 who are suffering from congenital heart disease (CHD)."

Answered by AI

Does the research include geriatric participants?

"Patients that meet the standards of this medical study must be between 10 and 18 years old. There are 120 trials open to minors, while a total of 273 clinical trails accept seniors over 65."

Answered by AI
~24 spots leftby Dec 2025